Cargando…
Risk of infection in elderly patients with AML and MDS treated with hypomethylating agents
The aim of this small volume is to raise awareness among Italian hematologists using hypomethylating drugs about risk - and even more important about “risk management” - and the treatment of the infectious events that may arise during therapy with these drugs. Since we wanted this review to be an ex...
Autores principales: | Livio, Pagano, Alessandro, Busca, Anna, Candoni, Marianna, Criscuolo, Matteo, Giovanni Della Porta, Luana, Fianchi, Federica, Lessi, Francesco, Marchesi, Maria, Teresa Voso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502134/ http://dx.doi.org/10.23750/abm.v89i11-S.7988 |
Ejemplares similares
-
Treatment of Low-Blast Count AML using Hypomethylating Agents
por: De Bellis, Eleonora, et al.
Publicado: (2017) -
Similarities and Differences Between Therapy-Related and Elderly Acute Myeloid Leukemia
por: D’Alò, Francesco, et al.
Publicado: (2011) -
Beyond the Edge of Hypomethylating Agents: Novel Combination Strategies for Older Adults with Advanced MDS and AML
por: Kubasch, Anne Sophie, et al.
Publicado: (2018) -
Hypomethylating Agents (HMAs) as Salvage Therapy in Relapsed or Refractory AML: An Italian Multicentric Retrospective Study
por: Lessi, Federica, et al.
Publicado: (2021) -
Therapy-related myeloid neoplasms: clinical perspectives
por: Fianchi, Luana, et al.
Publicado: (2018)